Guardant Health, INC Form 4 insider transactions

NASDAQ
Michael Bell, CFO of Guardant Health, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.
NASDAQ
AmirAli Talasaz, Co-CEO of Guardant Health, reports the acquisition and disposal of common stock related to the vesting of restricted stock units.
NASDAQ
Director Steve Krognes reported a transaction involving Guardant Health, Inc. stock on September 30, 2024.
NASDAQ
Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reported the vesting of restricted stock units and associated tax withholding, resulting in changes to his beneficial ownership of company stock.
NASDAQ
Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. stock and restricted stock units.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, Inc., exercised stock options and disposed of shares to cover tax withholding obligations.
NASDAQ
Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
NASDAQ
Chief Information Officer of Guardant Health, Kumud Kalia, reports the vesting of restricted stock units and associated tax withholding.
NASDAQ
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.
NASDAQ
Chief Medical Officer of Guardant Health, Craig Eagle, reports the vesting of restricted stock units and associated tax withholding.
NASDAQ
Michael Bell, CFO of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports a transaction involving common stock to cover tax withholding obligations.
NASDAQ
Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.
NASDAQ
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options and disposed of restricted stock units on September 4, 2024.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, Inc., reported the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
Chief Information Officer of Guardant Health, Kumud Kalia, reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and related tax withholding.
NASDAQ
Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.
NASDAQ
Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. common stock and derivative securities.
NASDAQ
Director Myrtle S. Potter reports the vesting and disposal of restricted stock units in Guardant Health, Inc.
NASDAQ
Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options on August 4, 2024, acquiring 66 shares of common stock.
NASDAQ
Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
NASDAQ
Manuel Hidalgo Medina, a director of Guardant Health, Inc., reported the acquisition of stock options and restricted stock units on July 17, 2024.
NASDAQ
Director Tariq Musa reported the vesting and disposal of restricted stock units in Guardant Health, Inc.
NASDAQ
Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
NASDAQ
Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition of 66 shares of common stock on July 4, 2024, through the vesting of restricted stock units.
NASDAQ
John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
NASDAQ
Kumud Kalia, Chief Information Officer of Guardant Health, reports the acquisition and disposal of common stock related to restricted stock units.
NASDAQ
Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.